CANCER THERAPY WITH CHECKPOINT INHIBITORS: ESTABLISHING A ROLE FOR OPHTHALMOLOGY

被引：14
作者：
Davis, Mary Elizabeth [1 ]
Francis, Jasmine H. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Nursing, Evidence Based Practice, 1275 York Ave, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Surg, Ophthalm Oncol Serv, New York, NY 10021 USA
来源：
SEMINARS IN ONCOLOGY NURSING | 2017年 / 33卷 / 04期
关键词：
immunotherapy; checkpoint inhibitor; eye; toxicity; interprofessional collaboration; management; PEMBROLIZUMAB-INDUCED UVEITIS; METASTATIC MELANOMA; IPILIMUMAB TREATMENT; ADVERSE EVENTS; CUTANEOUS MELANOMA; ANTIGEN-4; BLOCKADE; PATIENT; AUTOIMMUNITY; IMMUNOTHERAPY; COMPLICATIONS;
D O I：
10.1016/j.soncn.2017.08.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OBJECTIVE: To discuss interprofessional collaboration between the primary oncology clinicians and specialists in the management of immune-related ocular toxicities. DATA SOURCES: Peer-reviewed articles, case reports and systematic reviews. CONCLUSION: Accurate ophthalmologic assessment is critical for the prevention and treatment of ocular toxicities associated with immunotherapy.
引用
收藏
页码：415 / 424
页数：10
相关论文
共 48 条
[1]  
Aaberg MT, 2016, RETIN CASES BRIEF RE, P1
[2]   Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports [J].
Abdel-Wahab, Noha ;
Shah, Mohsin ;
Suarez-Almazor, Maria E. .
PLOS ONE, 2016, 11 (07)
[3]   A case of bilateral uveitis and papillitis in a patient treated with pembrolizumab [J].
Abu Samra, Khawla ;
Valdes-Navarro, Manuel ;
Lee, Stacey ;
Swan, Robert ;
Foster, C. Stephen ;
Anesi, Stephen D. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (03) :E46-E48
[4]   Emerging toxicities in the treatment of non-small cell lung cancer: Ocular disorders [J].
Agustoni, Francesco ;
Platania, Marco ;
Vitali, Milena ;
Zilembo, Nicoletta ;
Haspinger, Eva ;
Sinno, Valentina ;
Gallucci, Rosaria ;
de Braud, Filippo ;
Garassino, Marina Chiara .
CANCER TREATMENT REVIEWS, 2014, 40 (01) :197-203
[5]   Autoimmunity associated with immunotherapy of cancer [J].
Amos, Sally M. ;
Duong, Connie P. M. ;
Westwood, Jennifer A. ;
Ritchie, David S. ;
Junghans, Richard P. ;
Darcy, Phillip K. ;
Kershaw, Michael H. .
BLOOD, 2011, 118 (03) :499-509
[6]   Ocular and orbital side-effects of checkpoint inhibitors: a review article [J].
Antoun, Joelle ;
Titah, Cherif ;
Cochereau, Isabelle .
CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) :288-294
[7]   Case of acute anterior uveitis and Vogt-Koyanagi-Harada syndrome-like eruptions induced by nivolumab in a melanoma patient [J].
Arai, Takashi ;
Harada, Kazutoshi ;
Usui, Yoshihiko ;
Irisawa, Ryokichi ;
Tsuboi, Ryoji .
JOURNAL OF DERMATOLOGY, 2017, 44 (08) :975-976
[8]   Melanoma-Associated Retinopathy Treated with lpilimumab Therapy [J].
Audemard, A. ;
de Raucourt, S. ;
Miocque, S. ;
Comoz, F. ;
Giraud, J. M. ;
Dreno, B. ;
Bienvenu, B. ;
Rogerie, M. -J. ;
Dompmartin, A. .
DERMATOLOGY, 2013, 227 (02) :146-149
[9]   Posterior subcapsular cataracts and hypotony secondary to severe pembrolizumab induced uveitis: Case report [J].
Basilious, Alfred ;
Lloyd, John C. .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2016, 51 (01) :E4-E6
[10]  
BECKER BERNARD, 1965, INVEST OPHTHALMOL, V4, P198
12345